Project

Technology of three-dimensional organ bioprinting.

Three-dimensional organ bioprinting could be a solution for millions of people who require reconstruction or transplantation of defective or entirely lost organs, as well as well as for  immune compatibility problems. 

1. All investigations are performed on 3D bioprinter of  original construction \ design;

2. “Frameless method” - presents no limits attributable to frame methods of tissue reconstruction (no need in difficult-to-obtain frame - leached cadaveric organ or artificial frame);

3.  Ideally, the technology requires autologous stem patient’s cells, thus to eliminate the problem of immune incompatibility;  

Market

The “3D Bioprinting Market, 2014-2030” report provides an extensive study of the emerging market of complex organs (kidney, heart, liver), cartilaginous tissue (from 131 million US dollars in 2024 year to 3.6 billion US dollars in 2030 year), skin (conservative estimate of skin market alone: 4 310 billion US dollars by 2030 year). In the short term, the agency expects forthcoming results of scientific research work in Drug Testing by 2018 year.   Every day, about 17 patients die waiting for surgery in the USA alone, and every 13 minutes a new name appears on the waiting list.   Approximately 25-30% of patients perish in the queue for transplantation. Organ deficit remains a global unsolved problem.  As at the start  of 2014 year, the Laboratory for Biotechnological Research “3D Bioprinting Solutions” was one of 10 private laboratories, who develop own three-dimensional bioprinting technology and bioprinter of own original construction and design. Organ bioprinting is recognized by expert organizations as a breakthrough technology;  The development of this technology will influence the following fields: pharmaceutics; clinical trials and laboratory studies, methods of diagnostics; IT field; food industry; light industry (leather goods), etc. 


Company

 

Headquartered in Moscow, Russia, 3D Bioprinting Solutions is a biotech R&D  company focusing on 3D bioprinting technology and working on the whole range of the hardware, materials, technologies, and products constituting this nascent industry. 3D Bioprinting Solutions was established in 2013 and since then has built a wide net of partners all over the world.

 

1. We have designed and produced Russian's first  3D bioprinter; original technical and engineering solution are based on special features of own bioprinting technology.  Patent application submitted.

2. Unique software has been developed;

3. Research continues into bioreactor and other elements of the biofabrication technological platform are in process;

4.   In creating our own bio-ink, we have developed the technology of large-scale manufacturing of tissue spheroids; the bio-ink manufacturing process has been developed and standardized.

5. An ultra-modern, fully-equipped, biotechnology research laboratory has been built in Moscow;

6. An international multi-disciplinary team of researchers, engineers and management has been formed.  

7. An intellectual potential and the unique experience of leading experts in the field of regenerative medicine have been incorporated; collaboration between research groups, strictly adherent to the principles of evidence-based medicine, is carried out at the international level;

8. Research work is performed in accordance with the approved concept under the supervision of V. Mironov, a tissue engineer and inventor of the 3D organs printing technology, MD, PhD, professor, 3D Technologies Department, CTI, Brazil; engineering School of the Department of Chemical and Biological Engineering of the Virginia State University, USA.  Professor Mironov is also the author of such patents as «Production of vascular prostheses  with the use of nanofibers», «Device for production of tissue spheroids», «Hydrogel for three-dimensional tissue constructs», etc. 

9. The first organ-like construct of mouse's thyroid gland has been printed.

10. The scientific grant "Development and Optimization of technology of 3D Bioprinting using original 3d Bioprinter" has been recieved from Skolkovo.


Team [12]

Ostrovsky Alexander
Ostrovsky Alexander

Cofounder. Managing partners of 3D Bioprinting Solutions....

Mironov Vladimir
Mironov Vladimir

M.D., Ph.D., Head of Research at the Laboratory for Biotechnological...

Smirnova Julia
Smirnova Julia

Marketing Director at 3D Bioprinting Solutions, Member of...

Inna Pantylina
Inna Pantylina

Director for Public Relations of 3D Bioprinting Solutions...

Usef Hesuani
Usef Hesuani

Cofounder. Managing partners of 3D Bioprinting Solutions....

Yelena A. Bulanova
Yelena A. Bulanova

Ph.D., Head of the Laboratory of Cell Technologies at 3D Bioprinting...